1. Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients

   • Marco Tampellini
   • Alfredo Berruti
   • Luigi Dogliotti

   Clinical trial 03 May 2006 Pages: 241 - 248

2. Essiac^® and Flor-Essence^® herbal tonics stimulate the in vitro growth of human breast cancer cells

   • Kristen S. Kulp
   • Jennifer L. Montgomery
   • L. Michelle Bennett

   OriginalPaper 16 March 2006 Pages: 249 - 259

3. Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density

   • Shinichi Tsutsui
   • Hiroshi Inoue
   • Masaki Mori

   Preclinical study 15 March 2006 Pages: 261 - 266

4. Clinicopathologic factors associated with false negative FDG–PET in primary breast cancer

   • Rakesh Kumar
   • Anil Chauhan
   • Abass Alavi

   OriginalPaper 23 March 2006 Pages: 267 - 274

5. Chemotherapy versus ovarian ablation as adjuvant therapy for breast cancer: impact on health-related quality of life in a randomized trial

   • Mogens Groenvold
   • Peter M. Fayers
   • Henning T. Mouridsen

   Clinical trial 16 March 2006 Pages: 275 - 284

6. Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians

   • A Nkondjock
   • A. Robidoux
   • P. Ghadirian

   Epidemiology 16 March 2006 Pages: 285 - 294

7. Expression of PEA3 and Lack of Correlation Between PEA3 and HER-2/neu Expression in Breast Cancer

   • Wei-Ya Xia
   • Huang-Chun Lien
   • Mien-Chie Hung

   Original report 03 June 2006 Pages: 295 - 301

8. Increased prevalence of prior breast cancer in women with newly diagnosed diabetes

   • Lorraine L. Lipscombe
   • Pamela J. Goodwin
   • Janet E. Hux

   Epidemiology 15 March 2006 Pages: 303 - 309

9. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases

   • Amit Goyal
   • Anthony Douglas-Jones
   • Robert E Mansel

   Clinical trial 22 March 2006 Pages: 311 - 314

10. The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth

    • Jana Divisova
    • Isere Kuiatse
    • Adrian V. Lee

    OriginalPaper 16 March 2006 Pages: 315 - 327

11. Predictors of local recurrence after conservative surgery and whole-breast irradiation

    • Giampiero Ausili Cèfaro
    • Domenico Genovesi
    • Marta Di Nicola

    Clinical trial 23 March 2006 Pages: 329 - 335

12. Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer

    • Kyeongmee Park
    • Sehwan Han
    • Kyoung-Mee Kim

    Original report 24 February 2006 Pages: 337 - 342

13. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective

    • Arti Hurria
    • Shari Goldfarb
    • Clifford Hudis

    Clinical trial 16 March 2006 Pages: 343 - 348

14. Diabetes mellitus and breast cancer: a retrospective population-based cohort study

    • Lorraine L. Lipscombe
    • Pamela J. Goodwin
    • Janet E. Hux

    Epidemiology 16 March 2006 Pages: 349 - 356

15. Isolation and characterization of a breast progenitor epithelial cell line with robust DNA damage responses

    • Kate C. Shen
    • Fred Miller
    • Y. Alan Wang

    Preclinical study 16 March 2006 Pages: 357 - 364

16. High Prognostic Significance of Residual Disease After Neoadjuvant Chemotherapy: a Retrospective Study in 710 Patients with Operable Breast Cancer

    • Sophie Catherine Abrial
    • Frédérique Penault-Llorca
    • Philippe Chollet

    Erratum 22 June 2006 Pages: 365 - 365